Short Interest in Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Increases By 80.0%

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) saw a significant increase in short interest during the month of June. As of June 15th, there was short interest totalling 900 shares, an increase of 80.0% from the May 31st total of 500 shares. Based on an average daily volume of 4,200 shares, the days-to-cover ratio is presently 0.2 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Stock Performance

Shares of Harrow Health, Inc. 11.875% Senior Notes due 2027 stock remained flat at $26.72 during trading on Friday. The stock had a trading volume of 1,320 shares, compared to its average volume of 3,981. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a twelve month low of $22.71 and a twelve month high of $27.72. The stock has a 50 day moving average price of $26.34 and a two-hundred day moving average price of $26.12.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, April 30th. Shareholders of record on Monday, April 15th were given a $0.7422 dividend. This represents a $2.97 annualized dividend and a yield of 11.11%. The ex-dividend date was Friday, April 12th.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Company Profile

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.